/Investor DB

1921 Ventures

Venture capital

Vienna · Pre-Seed–Series A · 1 people tracked

Find your way into 1921 Ventures

Sign up to find every way you can get introduced to 1921 Ventures

  • Your email: who you already know at 1921 Ventures, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the 1921 Ventures team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

1921 Ventures invests in early-stage companies tackling Type 1 Diabetes and the diseases that commonly take lives, including cardiovascular, renal, neurodegenerative, and metabolic conditions. The fund backs mission-driven founders building either tech-enabled or biology-driven solutions, with the standard that a company's success should translate into lives saved and meaningful market recognition. It typically provides first money in through select Series A, leading pre-seed and seed rounds and following in later stages. The fund embeds portfolio companies within the global T1D community and vice versa, drawing on a wide network of clinicians, researchers, patients, advocates, and investors. Targeting roughly a €10M fund size, it must deploy at least 70% of capital in the EU.

Source: firm website, verified Oct 2, 2026.

Stage
Pre-Seed–Series A
Check
$200K – $1.5M
HQ
Vienna, AT
Leads rounds
Leads
Instruments
Equity
Founded
2024
AUM
$10M
Tracked investments
14

Team · 1 people

from the firm's website

What they invest in

from 3 of 14 portfolio companies

Climate Tech ×1Deep Tech ×1Digital Health ×1Fintech ×1Healthtech ×1Impact & Social Good ×1InsurTech ×1SaaS ×1

Investments · 14 tracked

founders shown can be your intro path
Charitecharite.de
Childrenwithdiabeteschildrenwithdiabetes.com
Diabettechdiabettech.com
Dr. Julia Mader, MUG, Austriamedunigraz.at
Dr. Martin Tauschmann, WMU, Austriameduniwien.ac.at
Encotecencotec.at
Hihi.healthin

hi.health by Pliant is a cashless claims and payments platform for insurers, embedding Visa card-based payments directly into the claims process to enable real-time provider settlement, fraud prevention, and configurable spend controls.

FintechInsurTechSaaS

Co-investorsHaymaker VenturesKinled Holding

Klingerklinger.io
mySugrmysugr.com

mySugr is a mobile app for diabetes management that allows users to log blood sugar levels, meals, and activity data, track patterns, and share reports with healthcare providers.

Digital HealthHealthtechWellness & Fitness

Co-investorsHansmann Family OfficePUSH Ventures

Next Cell Pharma ABnextcellpharma.com
Norrsken VCnorrsken.vc

Norrsken VC is an early-stage venture capital firm investing in technology companies addressing large-scale global challenges across energy, industry, and healthcare.

Climate TechDeep TechImpact & Social Good

Co-investorsKfW CapitalSella Direct Ventures

Pioneerspioneers.io
ResearchGateresearchgate.net

Professional network for scientists and researchers.

Co-investorsAglae VenturesCapnamicCipio PartnersTenaya CapitalWessel ManagementAccel+2 more

Uni Bayreuthuni-bayreuth.de

Frequently asked questions

How many investments has 1921 Ventures made?
1921 Ventures has 14 tracked investments.
What stage does 1921 Ventures invest at?
1921 Ventures invests at the Pre-Seed, Seed, Series A stages.
What is 1921 Ventures's typical check size?
1921 Ventures typically writes checks of $200K – $1.5M.
What sectors does 1921 Ventures focus on?
1921 Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is 1921 Ventures located?
1921 Ventures is headquartered in Vienna, AT.
Does 1921 Ventures lead rounds?
Yes, 1921 Ventures leads investment rounds.